Fresenius SE & Co KGaA (WBO:FRE)

€ 33.87 -0.84 (-2.42%) Market Cap: 19.03 Bil Enterprise Value: 29.42 Bil PE Ratio: 0 PB Ratio: 1.01 GF Score: 60/100

Q3 2024 Fresenius SE & Co KGaA Earnings Call Transcript
2 days ago

€34.71 (+3.06%)

Earnings
Q2 2024 Fresenius SE & Co KGaA Earnings Call Transcript
Jul 31, 2024

€33.17 (+3.72%)

Earnings
Q1 2024 Fresenius SE & Co KGaA Earnings Call Transcript
May 08, 2024

€28.47 (+1.28%)

Earnings
Full Year 2023 Fresenius SE & Co KGaA Earnings Call Transcript
Feb 21, 2024

€26.2 (+0.61%)

Earnings
Q3 2023 Fresenius SE & Co KGaA Earnings Call Transcript
Nov 02, 2023

€25.64 (+5.78%)

Earnings
Q2 2023 Fresenius SE & Co KGaA Earnings Call Transcript
Aug 02, 2023

€28.54 (-0.49%)

Earnings
Fresenius SE & Co KGaA Capital Markets Day 2023 Transcript
May 25, 2023
Fresenius SE & Co KGaA Annual Shareholders Meeting Transcript
May 17, 2023
Q1 2023 Fresenius SE & Co KGaA Earnings Call Transcript
May 09, 2023

€26.94 (+6.57%)

Earnings
Q4 2022 Fresenius SE & Co KGaA Earnings Call Transcript
Feb 22, 2023

€27.57 (-4.67%)

Earnings
Q3 2022 Fresenius SE & Co KGaA Earnings Call Transcript
Nov 01, 2022

€23.29 (-0.26%)

Earnings
Preliminary Q2 2022 Fresenius SE & Co KGaA Earnings Call Transcript
Jul 28, 2022

€25.04 (-8.04%)

Earnings
Fresenius SE & Co KGaA Annual Shareholders Meeting Transcript
May 13, 2022
Q1 2022 Fresenius SE & Co KGaA Earnings Call Transcript
May 04, 2022

€34.82 (+2.50%)

Earnings
Fresenius SE & Co KGaA and Fresenius Kabi AG Conference Call on the Acquisition of Ivenix Inc and Majority Stake in mAbxience SA Call Transcript
Mar 31, 2022
Full Year 2021 Fresenius SE & Co KGaA Earnings Call Transcript
Feb 22, 2022

€33.23 (-9.12%)

Earnings
Fresenius SE & Co KGaA at JPMorgan Healthcare Conference (Virtual) Transcript
Jan 10, 2022
Q3 2021 Fresenius SE & Co KGaA Earnings Call Transcript
Nov 02, 2021

€40.72 (+2.23%)

Earnings
Q2 2021 Fresenius SE & Co KGaA Earnings Call Transcript
Jul 30, 2021

€44.3 (-3.80%)

Earnings
Fresenius SE & Co KGaA at Goldman Sachs Global Healthcare Conference (Virtual) Transcript
Jun 09, 2021
Fresenius SE & Co KGaA Annual Shareholders Meeting Transcript
May 21, 2021
Q1 2021 Fresenius SE & Co KGaA Earnings Call Transcript
May 06, 2021

€41.44 (+0.27%)

Earnings
Full Year 2020 Fresenius SE & Co KGaA Earnings Call Transcript
Feb 23, 2021

€35.62 (-0.56%)

Earnings
Fresenius SE & Co KGaA at JPMorgan Healthcare Conference (Virtual) Transcript
Jan 11, 2021
Q3 2020 Fresenius SE & Co KGaA Earnings Call Transcript
Oct 29, 2020

€31.46 (-2.35%)

Earnings
Fresenius SE & Co KGaA Annual Shareholders Meeting Transcript
Aug 28, 2020
Q2 2020 Fresenius SE & Co KGaA Earnings Call Transcript
Jul 30, 2020

€42.23 (-6.95%)

Earnings
Fresenius SE & Co KGaA at Goldman Sachs Global Healthcare Conference (Virtual) Transcript
Jun 10, 2020
Q1 2020 Fresenius SE & Co KGaA Earnings Call Transcript
May 06, 2020

€39.73 (+0.61%)

Earnings
Full Year 2019 Fresenius SE & Co KGaA Earnings Call Transcript
Feb 20, 2020

€49.75 (+2.55%)

Earnings
Fresenius SE & Co KGaA at JPMorgan Healthcare Conference Transcript
Jan 13, 2020
Fresenius SE & Co KGaA at Deutsche Bank Depositary Receipts Virtual Investor Conference Transcript
Nov 13, 2019
Q3 2019 Fresenius SE & Co KGaA Earnings Call Transcript
Oct 29, 2019

€45.68 (+4.12%)

Earnings
Q2 2019 Fresenius SE & Co KGaA Earnings Call Transcript
Jul 30, 2019

€44.91 (-1.61%)

Earnings
Fresenius SE & Co KGaA Annual Shareholders Meeting Transcript
May 17, 2019
Q1 2019 Fresenius SE & Co KGaA Earnings Call Transcript
May 02, 2019

€50.62 (+0.24%)

Earnings
Full Year 2018 Fresenius SE & Co KGaA Earnings Call Transcript
Feb 20, 2019

€48.88 (+4.79%)

Earnings

Fresenius SE & Co KGaA at Goldman Sachs Global Healthcare Conference (Virtual) Transcript

Jun 09, 2021 / 12:00PM GMT

Release Date Price: €45.21 (+0.85%)

Transcript

Veronika Dubajova

Goldman Sachs Group, Inc., Research Division - Equity Analyst

Good afternoon. Good morning, and good evening, ladies and gentlemen, and thank you for joining us second day of the Goldman Sachs 42nd Annual Global Healthcare Conference. It is with great pleasure that I am kicking us off today with Fresenius SE represented by Stephan Sturm, Chairman of the Management Board; and Markus Georgi, Head of IR. Thank you guys for being here.

Stephan Sturm

Fresenius SE & Co. KGaA - CEO, President & Chairman of Management Board - Fresenius Management SE

Hope everybody is well.

Veronika Dubajova

Goldman Sachs Group, Inc., Research Division - Equity Analyst

Excellent. I'm going to kick us off with some questions, but just from a logistical perspective, if anyone would like me to ask a question, please, you can either submit them on the webcast chat or you can e-mail me directly at [email protected], and I promise I will ask that question. But let me kick off with my own, if that's all right,

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.